¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"tumor lymphnode metastasis classification"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® metastasis ÇÑ±Û ÀüÀÌ
¼³¸í   
  ´Ù¸¥ °÷À¸·Î ¿Å°Ü °£´Ù´Â ¶æÀ¸·Î ¾î¶² Á¾¾çÀÇ ¹ß»ý½Ã ±×°ÍÀÌ ¾Ç¼ºÀÎÁö È¤Àº ¾ç¼ºÀÎÁö ±¸º°Çϴ ¹æ¹ý Áß¿¡ °¡Àå Áß¿äÇÑ °ÍÀÌ ÀÌ "ÀüÀÌ"ÀÌ´Ù. ´Ù¸¥ °÷À¸·Î ÀüÀ̰¡ °¡´ÉÇϸé, ±×°ÍÀº ¾Ç¼ºÀ¸·Î »ý¸í¿¡ ÁöÀåÀ» ÁÙ À§ÇèÇÑ Á¾¾çÀÓÀ» ¶æÇϰí ÀüÀ̰¡ ¾øÀ¸¸é, ´ÜÁö ±× ±â°ü¿¡¸¸ Ä§ÀÔÇϴ ¾ç¼ºÀ» ¶æÇÑ´Ù.
¿µ¹® solid tumor ÇÑ±Û °íÇüÁ¾¾ç
¼³¸í   
  ¼¼Æ÷·Î ²Ë Âù Á¾¾çÀ» ¸»ÇÔ. ¹éÇ÷º´ µîÀÇ Ç÷¾×¾Ï°ú °°ÀÌ ÇüŸ¦ ÃëÇÏÁö ¾Ê°í ¾×üÀΠ»óÅÂÀÇ ¾Ï°ú ´ëÁ¶µÇ´Â ¿ë¾î·Î¼­ ´Ü´ÜÇÑ µ¢¾î¸®·Î ±¸¼ºµÈ ¾Ç¼ºÁ¾¾çÀÌ´Ù. ´ëºÎºÐÀÇ Á¾¾çÀÌ ÀÌ¿¡ ÇØ´çÇÑ´Ù. Æ¯È÷ Ç¥ÇÇÁ¶Á÷¿¡¼­ ±â¿øÇÑ Á¾¾çÀ» ¸»ÇÑ´Ù.
¿µ¹® ulcerating tumor ÇÑ±Û ±Ë¾ç¼º Á¾¾ç
¼³¸í   
  Á¾¾çÀǠǥ¸é¿¡ ±Ë¾çÀÌ ¹ß»ýÇϴ °Í. ´ë°³, ¸Å¿ì »¡¸® ÀÚ¶ó´Â Á¾¾ç¿¡¼­ Ç÷·ù °ø±ÞÀÌ Á¾¾ç¼¼Æ÷ÀÇ ÀÚ¶ó´Â ¼Óµµ¸¦ °¨´çÇÏÁö ¸øÇØ Á¾¾çÁ߽ɺΠÁ¶Á÷ÀÌ ±«»ç¿¡ ºüÁ® ±Ë¾çÀ» Çü¼ºÇϴ °æ¿ì°¡ ¸¹´Ù. À°¾ÈÀ¸·Î º¸¸é »¡°²°í, ¿­À̳ª¸ç, ÁöÀúºÐÇØ º¸ÀδÙ.
¿µ¹® brain tumor ÇÑ±Û ³úÁ¾¾ç
¼³¸í   
  ³úÁ¾¾çÀ̶õ ³ú¿Í ³úÁ¶Á÷¿¡¼­ »ý±ä Á¾¾çÀ» ÁöĪÇϴ ¸»ÀÌ´Ù. ±×·¯³ª ´ë°³ ³ÐÀº Àǹ̷Π»ç¿ëÇÒ °æ¿ì¿¡´Â ¸Ó¸®»À¼ÓÀÇ °ø°£ÀΠµÎ°³°­¼Ó¿¡ »ý±â´Â ¸ðµç Á¾¾çÀ» À̸£´Â ¸»·Î »ç¿ëµÈ´Ù.
  
  ³úÁ¾¾çÀº ÇÑÁ¤µÈ °ø°£ÀΠµÎ°³°­¿¡¼­ ¹ß»ýÇϹǷΠÁ¾¾çÀÌ ±×´ÙÁö Å©Áö ¾Ê¾Æµµ Á¤»óÀûÀΠÁ¶Á÷À» ¾Ð¹ÚÇϰԠµÇ°í, µÎ°³°­³»ÀÇ ¾Ð·ÂÀ» ³ôÀδÙ. ÀÌ·± Æ¯Â¡¿¡ ÀÇÇØ¼­ ³úÁ¾¾çÀÇ Áõ»óÀº ´Ù¸¥ Á¾¾ç°ú ´Þ¸®, Á¾¾ç ±× ÀÚüÀÇ Áõ»óº¸´Ùµµ µÎ°³³»¾Ð»ó½Â°ú Á¤»óÁ¶Á÷ÀÇ ¾Ð¹Ú¿¡ ÀÇÇÑ Áõ»óÀÌ ¸¹´Ù. µÎ°³³»¾Ð(³ú¾Ð)ÀÇ »ó½Â¿¡ ÀÇÇÑ Áõ»óÀ¸·Î´Â µÎÅë, ±¸ÅäµîÀÌ ÀÖÀ¸¸ç, Áö¼ÓÀûÀΠ³ú¾Ð»ó½Â¿¡ ÀÇÇØ¼­ À¯µÎºÎÁ¾(papilledema)ÀÌ °üÂûµÇ±âµµ ÇÑ´Ù. ±×¸®°í Á¤»óÀûÀΠ³úÁ¶Á÷ÀÇ ¾Ð¹Ú°ú Á¾¾çÀÌ »ý±ä ºÎÀ§ÀÇ ±â´ÉÀÇ °áÇÕ¿¡ ³úÀÇ ±× ºÎºÐ¿¡ ÇØ´çÇϴ ±â´ÉÀÇ »ó½ÇÀ» º¸°ÔµÈ´Ù.
¿µ¹® epithelial tumor ÇÑ±Û »óÇǼºÁ¾¾ç
¼³¸í   
  Á¤»ó »ç¶÷ÀÇ Á¶Á÷Àº Ã¼Ç¥¸éÀ» µ¤´Â ¿ªÇÒÀ» Çϴ Á¶Á÷°ú, ÁַΠ¹ß»ý±âÀÇ Á߹迱¿¡¼­ ºÐÈ­ÇÑ °£¿±Á¶Á÷¿¡¼­ À¯·¡Çϴ °áÇÕÁ¶Á÷, »À, ¿¬°ñ, Áö¹æ, ±ÙÀ°, Ç÷°ü µîÀÇ Á¶Á÷ÀÇ µÎ °èÅëÀ¸·Î ³ª´­ ¼ö ÀÖ´Ù. ÀüÀÚ¸¦ »óÇǼº Á¶Á÷, ÈÄÀÚ¸¦ ºñ»óÇǼº Á¶Á÷À̶ó Çϸ砱נ°¢°¢À» ±¸¼ºÇϴ ¼¼Æ÷¸¦ »óÇǼº ¼¼Æ÷, ºñ»óÇǼ¼Æ÷¶ó ÃÑĪÇÑ´Ù. »óÇǼº ¼¼Æ÷¿¡¼­ ±â¿øÇϴ Á¾¾çÀÌ »óÇǼº Á¾¾çÀ̸ç, ±ÙóÀÇ Á¶Á÷À¸·Î Ä§Åõ³ª Ç÷·ù, ¸²ÇÁÀÇ Á¶Á÷À» Å¸°í ¿ø°Å¸®ÀÇ Àå±â·Î À̵¿ÇÏÁö ¾Ê´Â ¾ç¼ºÁ¾¾ç¿¡´Â ¼±Á¾, À¯µÎÁ¾ µîÀÌ ÀÖ°í ¾ç¼º°ú ¹Ý´ë·Î ±ÙóÀÇ Á¶Á÷À¸·Î Ä§Åõ, ¿ø°ÝÀå±â·Î ÀüÀÌÇϴ ¾Ç¼ºÁ¾¾çÀ» ¸ðµÎ ÅëĪÇÏ¿© ¾ÏÁ¾(carcinoma)À̶ó°í ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adnexal metastasis
    ÀڱúμӱâÀüÀÌ
  • hematogenous metastasis
    Ç÷ÇàÀüÀÌ
  • lymph node metastasis
    ¸²ÇÁÀýÀüÀÌ
  • lymphogenous metastasis
    ¸²ÇÁ¼ºÀüÀÌ
  • metastasis
    ÀüÀÌ
  • osteoblastic metastasis
    »À¸ð¼¼Æ÷ÀüÀÌ
  • classification
    ºÐ·ù
  • International Classification of Disease
    ±¹Á¦Áúº´ºÐ·ù
  • Lancefield classification
    ·£½ºÇʵåºÐ·ù
  • numerical classification
    ¼öÄ¡ºÐ·ù, À¯»ç°è¼öºÐ·ù
  • phylogenetic classification
    °èÅë¹ß»ýÇÐÀûºÐ·ù
  • physical status classification
    ½Åü»óźзù
  • REAL classification
    ¸±ºÐ·ù
  • serological classification
    Ç÷ûÇÐÀûºÐ·ù
  • adenomatoid odontogenic tumor
    »ùÁ¾¸ð¾çÄ¡¿ø¼ºÁ¾¾ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • classification
    ºÐ·ù
  • metastasis
    ÀüÀÌ
  • lymph node metastasis
    ¸²ÇÁÀýÀüÀÌ
  • sex cord-stromal tumor tumor
    ¼º²ö°£ÁúÁ¾¾ç, ³­¼Ò¹öÆÀÁúÁ¾¾ç
  • tumor antigen
    Á¾¾çÇ׿ø
  • tumor suppressor gene
    Á¾¾ç¾ïÁ¦À¯ÀüÀÚ
  • tumor marker
    Á¾¾çÇ¥ÁöÀÚ
  • tumor size
    Á¾¾çÅ©±â
  • tumor
    Á¾¾ç
  • adenomatoid tumor
    »ù¸ð¾çÁ¾¾ç, »ùÁ¾´àÀºÁ¾¾ç
  • benign tumor
    ¾ç¼ºÁ¾¾ç
  • carcinoid tumor
    Ä«¸£½Ã³ëÀ̵åÁ¾¾ç
  • cystic tumor
    ³¶Á¾
  • desmoid tumor
    µ¥½º¸ðÀ̵åÁ¾¾ç
  • endodermal sinus tumor
    ³»¹è¿±±¼Á¾¾ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • tumor lymphnode metastasis classification
    Á¾¾ç¸²ÇÁÀýÀüÀ̺зù
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adnexal metastasis
    Àڱúμӱâ°üÀüÀÌ
  • classification
    ºÐ·ù
  • numerical classification
    ¼öÄ¡ºÐ·ù, À¯»ç°è¼öºÐ·ù
  • phylogenetic classification
    °èÅë¹ß»ýÇÐÀûºÐ·ù
  • physical status classification
    ½Åü»óźзù
  • serological classification
    Ç÷ûÇÐÀûºÐ·ù
  • socioeconomic classification
    »çȸ°æÁ¦ºÐ·ù
  • lymphogenous metastasis
    ¸²ÇÁÀüÀÌ
  • metastasis
    ÀüÀÌ
  • osteoblastic metastasis
    »ÀÇü¼ºÀüÀÌ, °ñÇü¼º¼ºÀüÀÌ
  • skipped metastasis
    µµ¾àÀüÀÌ, °Ç³Ê¶ÜÀüÀÌ
  • transplantation metastasis
    À̽ÄÀüÀÌ
  • adenomatoid tumor
    »ù¸ð¾çÁ¾¾ç, »ùÁ¾´àÀºÁ¾¾ç
  • adenomatoid odontogenic tumor
    »ù¸ð¾çÄ¡¾ÆÅ¿Á¾¾ç, »ù¸ð¾çÄ¡¾Æ¿øÀÎÁ¾¾ç
  • adrenal rest tumor
    ºÎ½ÅÀÜ·ùÁ¾¾ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hematogenous metastasis
    Ç÷Ç༺ ÀüÀÌ.
  • implantation metastasis
    Á¾¾ç¼¼Æ÷ÀÇ »õ±¹ºÎ·ÎÀÇ ÀüÀÌ.
  • pulmonary metastasis
    ÆóÀåÀüÀÌ.
  • pulmonary metastasis
    ÆóÀåÀüÀÌ(øËíóï®ì¹)
  • remote metastasis
    ¿ø°ÝÀüÀÌ(êÀ̰ï®ì¹)
  • FAB =>French-american-British leukemia classification
    FAB ¹éÇ÷º´ºÐ·ù
  • French-American-British leukemia classification
    FAB ¹éÇ÷º´ºÐ·ù
  • Internation Classification of Disease(ICD)
    ±¹Á¦Áúº´ºÐ·ù.
  • Kauffmann-White classification
    Ä«¿ìÇÁ¸¸-È­ÀÌÆ®Ç׿øºÐ·ù¹ý (»ì¸ð³Ú¶ó±Õ Ç׿øºÐ·ù¹ý)
  • Lukes-Collins classification
    ·è½º- Äݸ°½º ºÐ·ù
  • Runyon classification
    ·¯´Ï¿ÂºÐ·ù
  • phylogenic classification
    °èÅë¹ß»ýÇÐÀûºÐ·ù(¹ý)
  • Chinese hamster ovary tumor cell
    Áß±¹ÇÔ½ºÅÍ ³­¼Ò¼¼Æ÷, CHO¼¼Æ÷
  • Dermoid tumor
    À¯ÇÇÁ¾
  • Granulosa cell tumor
    °ú¸³¸·¼¼Æ÷Á¾¾ç(Î¨Ø£Ø¯á¬øàðþåË)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • tnm classifications ; tumor lymphnode metastasis classification
    TNMºÐ·ù ¡ìÁ¾¾ç, ¸²ÇÁÀý, ÀüÀ̵éÀ» Ç¥ÁØÀ¸·Î ÇÏ´Â ¾Ç¼ºÁ¾¾çÀÇ ºÐ·ù¹ý¡í
  • tumor,metastasis
    ÀüÀÌ(ï®ì¹)
  • cervical lymphnode
    ¸ñ¸²ÇÁÀý, °æºÎ¸²ÇÁÀý(¡­ï½).
  • inferior deep cervical lymphnode
    ¾Æ·¡¸ñ±íÀº¸²ÇÁÀý, ÇϽɰæ(ù»ä¢ )¸²ÇÁÀý.
  • lymphnode biopsy
    ¸²ÇÁÀý»ý°Ë(¡­Àý»ý°Ë).
  • lymphnode biopsy
    ¸²ÇÁÀý»ý°Ë(¡­ï½ßæËþ).
  • lymphnode enlargement
    ¸²ÇÁÀýºñ´ë(¡­ï½ÝþÓÞ).
  • lymphnode tuberculosis
    ¸²ÇÁÀý°áÇÙ(¡­ï½Ì¿ú·).
  • classification
    ºÐ·ù(¹ý)(ÝÂ×¾Ûö).
  • classification
    ºÐ·ù(¹ý)
  • classification, Kauffmann-White
    Ä«¿ìÇÁ¸¸-È­ÀÌÆ®Ç׿øºÐ·ù¹ý
  • classification, numerical
    ¼öÄ¡ºÐ·ù¹ý, À¯»ç°è¼öºÐ·ù¹ý
  • classification, phylogenetic
    °èÅë¹ß»ýÇÐÀûºÐ·ù¹ý
  • phylogenic classification
    °èÅë¹ß»ýÇÐÀûºÐ·ù(¹ý)
  • serological classification
    Ç÷ûÇÐÀû ºÐ·ù
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Deficiency (Monstrous tumor)
    °áÇÌ (±«¹°Á¾)
    [¿¾ ¿ë¾î] °áÇÌ
  • Monstrous tumor
    ±«¹°Á¾
    [¿¾ ¿ë¾î] ±«¹°Á¾
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • enzyme classification
    È¿¼Ò ºÐ·ù(ý£áÈÝÂ×¾)
  • metastasis
    ÀüÀÌ(ï®ì¹)
  • ectopic tumor
    ÀÌ¼Ò Á¾¾ç(ì¶á¶ðþåË)
  • Ehrlich ascites tumor
    ¿¡¸¦¸®È÷ º¹¼öÁ¾(ÜÙâ©ðþ)
  • primary tumor
    ¿ø¹ß¼º Á¾¾ç(ê«Û¡àõðþåË)
  • tumor angiogenesis facotr
    Á¾¾ç Ç÷°üÇü¼ºÀÎÀÚ(ðþåËúìηû¡à÷ì×í­)
  • tumor antigen
    Á¾¾çÇ׿ø(ðþåËù÷ê«)
  • tumor initiator
    Á¾¾ç °³½ÃÀÚ(ðþåËËÒã·í­)
  • tumor necrosis factor
    Á¾¾ç ±«»çÀÎÀÚ(ðþåËÎÕÞÝì×í­)
  • tumor progression
    Á¾¾çÁøÇà(ðþåËòäú¼)
  • tumor promoter
    Á¾¾çÃËÁøÀÚ(ðþåËõµòäí­)
  • tumor-specific transplantation antigen
    Á¾¾çƯÀÌ ÀÌ½Ä Ç׿ø(ðþåË÷åì¶ì¹ãÕù÷ê«)
  • tumor virus
    Á¾¾ç(ðþåË)¹ÙÀÌ·¯½º
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • TNM [=Tumor-Lymphnode-Metastasis] classification
    TNMºÐ·ù ¡ìÁ¾¾ç, ¸²ÇÁÀý, ÀüÀ̵éÀ» Ç¥ÁØÀ¸·Î ÇÏ´Â ¾Ç¼ºÁ¾¾çÀÇ ºÐ·ù¹ý¡í
  • cervical lymphnode
    ¸ñ¸²ÇÁÀý, °æºÎ¸²ÇÁÀý
  • classification
    ºÐ·ù¹ý
  • direct metastasis
    Á÷Á¢ÀüÀÌ
  • distant metastasis
    ¿ø°ÝÀüÀÌ
  • hematogenous metastasis
    Ç÷Ç༺ÀüÀÌ
  • metastasis
    ÀüÀÌ
  • osteoblastic metastasis
    °ñÇü¼º¼ºÀüÀÌ
  • remote metastasis
    ¿ø°ÝÀüÀÌ
  • skipped metastasis
    µµ¾àÀüÀÌ
  • benign tumor
    ¾ç¼ºÁ¾¾ç
  • brown tumor
    °¥»öÁ¾¾ç
  • carotid body tumor
    °æµ¿¸Æ¼ÒüÁ¾¾ç
  • giant cell tumor
    °Å¼¼Æ÷Á¾¾ç
  • glomus jugulare tumor
    °æÁ¤¸Æ±¸Á¾¾ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TNM primary tumor, regional nodes, metastasis [tumor staging]; thyroid node metastases; tumor node metas...
GTN   - Stages of GTN(FIGO, WHO)
    1. Stage O; Molar Pregnancy(H-Mole...
CEA Carcino-Embryonic Antigen [HP 1825-6]
  ; Oncofetal Antigens
  ; Glycopro...
AFP Alpha(¥á) Feto-Protein [HP 1826, 1858, 1859, 2265]
  ; Oncofetal Antigens
 &nbs...
TNM staging System standard Tumor, NOde & Metastasis staging system
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TNM Tumor Node Metastasis
MFS Metastasis-free survival
n 0 node metastasis
CART Classification And Regression Tree
ICNP International Classification for Nursing Practice
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cervical lymphnode
    ¸ñ ¸²ÇÁÀý, °æºÎ ¸²ÇÁÀý
  • lymphnode calcification
    ¸²ÇÁÀý, ¼®È¸È­
  • biochemical metastasis
    »ýÈ­ÇÐÀû ÀüÀÌ
  • bone metastasis
    °ñ ÀüÀÌ
  • lymph node metastasis
    ÀÓÆÄÀý ÀüÀÌ
    ¾ÏÁ¾ÀÌ ÀÓÆÄÀýÀ» ÅëÇØ ´Ù¸¥ Àå±â·Î ÀüÀ̵Ǵ °Í.
  • metastasis
    ÀüÀÌ
    1. ÇÑ ±â°ü ¶Ç´Â ÇÑ ºÎºÐ¿¡¼­ ±×¿Í Á÷Á¢ ¿¬°áµÇÁö ¾ÊÀº ´Ù¸¥ ±â°üÀ̳ª ºÎºÐÀ¸·Î ÁúȯÀÌ ¿Å°Ü°¡´Â °Í. À̶§ ÁúȯÀÇ ÀüÀÌ´Â ¾Æ¸¶µµ °áÇÙ±Õ°ú °°Àº º´¿ø±Õ¿¡ ÀÇÇØ ¿Å°ÜÁö°Å³ª ¾Æ´Ï¸é ¾Ç¼º Á¾¾ç ³»¿¡ ÀÖ´Â ¼¼Æ÷µé¿¡ ÀÇÇØ ¿Å°ÜÁú ¼öµµ ÀÖ´Ù. ÀüÀÌ·ÂÀº ¸ðµç ¾Ç¼º Á¾¾çÀÇ Æ¯Â¡ÀÌ´Ù. 2. º¹¼ö. metastases. º´¿ø±ÕÀÇ ¼ºÀåÀ̳ª Á¤»ó ¼¼Æ÷ÀÇ ¼ºÀåÀº º´Àû °úÁ¤ÀÌ ÁøÇàµÇ´Â ÀÏÂ÷ÀûÀÎ Àå¼Ò¿Í´Â ¸Ö¸® ¶³¾îÁ® ÀÖ´Ù.
  • osteoblastic metastasis
    °ñ Çü¼º¼º ÀüÀÌ
  • remote metastasis
    ¿ø°Ý ÀüÀÌ
  • Schnitzler's metastasis
    ½´´ÏÃú·¯ ÀüÀÌ
    º¹°­ Àå±âÀÇ ¿ø¹ß ¾ÏÀÇ ÇÑ ÀüÀÌ Çü½Ä.
  • skipped metastasis
    µµ¾à ÀüÀÌ
  • vaginal metastasis
    Áú ÀüÀÌ
  • Angle's classification of malocclusion
    ºÎÁ¤±³ÇÕÀÇ Angle ºÐ·ù
  • Angle's classification of malocclusion Class II
    ºÎÁ¤±³ÇÕÀÇ Angle ºÐ·ù 2±Þ
    ÇÏ¾Ç Á¦ 1´ë±¸Ä¡°¡ »ó¾Ç Á¦ 1´ë±¸Ä¡¿ÍÀÇ °ü°è¿¡¼­ ¿ø½É ȤÀº ÈĹ濡 À§Ä¡ÇÏ´Â ºÎÁ¤±³ÇÕ.
  • Angle's classification of malocclusion division 1
    ºÎÁ¤±³ÇÕÀÇ Angle ºÐ·ù 1·ù
    »óÇÏ¾Ç Á¦ 1´ë±¸Ä¡°¡ ¿ø½É±³ÇÕÀÇ ¾ç»óÀ» º¸À̸鼭 »ó¾Ç ÀüÄ¡ÀÇ °úµµÇÑ ¼øÃø °æ»ç°¡ Ư¡ÀÎ ºÎÁ¤±³ÇÕ.
  • Angle's classification of occlusion
    ±³ÇÕÀÇ Angle ºÐ·ù, ¾Þ±Û¾¾ ºÐ·ù
    1. »óÇÏ¾Ç ±¸Ä¡¿Í ÀýÄ¡ °ü°è¿¡ ±Ù°ÅÇÑ ±³ÇÕÀÇ ºÐ·ù. 2. óÀ½¿¡ ¾Þ±Û¿¡ ÀÇÇØ ±â¼úµÈ ÀüÈÄ¹æ ¾Ç°£ °ü°è¿¡ ´ëÇØ 4°¡Áö ÁÖ¿ä ±¸ºÐÀ¸·Î ¼³¸íµÇ¾ú´ø Á¦ 1´ë±¸Ä¡ÀÇ ±³ÇÕ ¾ç»ó¿¡ ±âÃʸ¦ µÐ ±³Çպзù¹ý.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
tumor 1. <oncology> An abnormal mass of tissue that results from excessive cell division that is uncontrolled and progressive, also called a neoplasm. Tumours perform no useful body function. They may be either benign (not cancerous) or malignant.
2. Swelling, one of the cardinal signs of inflammations, morbid enlargement.
Origin: L. Tumere = to swell
(12 May 1997)
tumor marker <investigation, oncology> A substance in the body that usually indicates the presence of cancer.
These markers are usually specific to certain types of cancer and are usually found in the blood or other tissue samples.
Examples are alphafetoprotein (AFP), human chorionic gonadotropin, and lactate dehydrogenase (LDH).
They may be indicators of tumour stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids.
(18 Jul 2002)
tumor necrosis factor <cytokine> Originally described as a tumour inhibiting factor in the blood of animals exposed to bacterial lipopolysaccharide or Bacille Calmette-Guerin.
Preferentially kills tumour cells in vivo and in vitro, causes necrosis of certain transplanted tumours in mice and inhibits experimental metastases. Human Tumour Necrosis factor alpha is a protein of 157 amino acids and has a wide range of pro inflammatory actions. Usually considered a cytokine.
Synonym: cachectin.
Acronym: TNF
(13 Nov 1997)
biochemical metastasis The transportation and induction of abnormal immunochemical specificities in apparently normal organs.
(05 Mar 2000)
calcareous metastasis The deposit of calcareous material in remote tissues in the event of extensive resorption of osseous tissue in caries, malignant neoplasms, and so on.
(05 Mar 2000)
metastasis 1. <cell biology, oncology> The transfer of disease from one organ or part to another not directly connected with it. It may be due either to the transfer of pathogenic microorganisms (for example, tubercle bacilli) or to transfer of cells, as in malignant tumours. The capacity to metastasize is a characteristic of all malignant tumours.
2. Pleural: metastases. A growth of pathogenic microorganisms or of abnormal cells distant from the site primarily involved by the morbid process.
Origin: Gr. Stasis = stand, stoppage
(12 Nov 1997)
haematogenous metastasis See: metastasis.
(05 Mar 2000)
satellite metastasis Metastasis within the immediate vicinity of a primary malignant neoplasm; e.g., skin adjacent to a melanoma.
(05 Mar 2000)
neoplasm metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. The ability to metastasize is characteristic of all malignant neoplasms.
(12 Dec 1998)
lymphatic metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system.
(12 Dec 1998)
lymphogenous metastasis See: metastasis.
(05 Mar 2000)
adansonian classification The classification of organisms based on giving equal weight to every character of the organism; this principle has its greatest application in numerical taxonomy.
Origin: M. Adanson
(05 Mar 2000)
Angle's classification of malocclusion A classification of different types of malocclusion, based on the mesiodistal relationship of the permanent molars upon their eruption and locking, and comprised of three classes; Class I: normal relationship of the jaws, wherein the mesiobuccal cusp of the maxillary first molar occludes in the buccal groove of the mandibular first permanent molar; Class II: distal relationship of the mandible, wherein the distobuccal cusp of the maxillary first permanent molar occludes in the buccal groove of the mandibular first molar, and further classified as Division 1, labioversion of maxillary incisor teeth, and Division 2, linguoversion of maxillary central incisors, both of which may be unilateral conditions; Class III: mesial relationship of the mandible, wherein the mesiobuccal cusp of the maxillary first molar occludes in the embrasure between the mandibular first and second permanent molars, further classified as a unilateral condition.
(05 Mar 2000)
aortic dissection: classification <radiology> DeBakey: I ascending aorta to arch with or without descending aorta (30%), II ascending aorta only (20%), III descending aorta to thoracic aorta (50%), Stanford: A involvement of ascending aorta (regardless of origin), B aortic arch and distal aorta see also: aetiology mnemomics: 1 A.D. (DeBakey), A = Ascending
(12 Dec 1998)
Arneth classification A classification of the polymorphonuclear neutrophils according to the number of their nuclear lobes.
See: Arneth stages.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • metastasis
    ÀüÀÌ;±ÞÀüȯ
  • tumor
    Á¾±â
  • tumor
    Á¾Ã¢;ºÎ±â;Á¾±â
  • classification
    µîºÐ
  • Dewey classification system
    µµ¼­ÀÇ µàÀÌ 10Áø ºÐ·ù¹ý
  • classification
    ºÐ·ù(¹ý);À¯º°;Á¾º°;ºÐ·ù(»ý¹°ÇлóÀÇ ºÐ·ù ¼ø¼­);µî±Þº°;µî±Þ ¸Å±è;±Þ¼öº°;µµ¼­ ºÐ·ù¹ý;(°ø¹®¼­ÀÇ)±â¹Ð Á¾º°
  • classification club
    Á÷¾÷º° Ŭ·´
  • classification schedule
    µµ¼­ ºÐ·ù À϶÷Ç¥
  • classification society
    ¼±±Þ Çùȸ(»ó¼±ÀÇ µî±ÞÀ» ¸Å±â´Â)
  • classification yard
    öµµ Á¶Â÷Àå
  • decimal classification
    µµ¼­ÀÇ ½ÊÁø ºÐ·ù¹ý
  • natural classification
    NATURAL SYSTEM
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á